182 related articles for article (PubMed ID: 7856728)
1. The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model.
Bronner MP; Culin C; Reed JC; Furth EE
Am J Pathol; 1995 Jan; 146(1):20-6. PubMed ID: 7856728
[TBL] [Abstract][Full Text] [Related]
2. bcl-2 protein expression in the Barrett's metaplasia-dysplasia-carcinoma sequence.
Goldblum JR; Rice TW
Mod Pathol; 1995 Oct; 8(8):866-9. PubMed ID: 8552577
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evaluation of bcl-2 oncoprotein in oral dysplasia and carcinoma.
Singh BB; Chandler FW; Whitaker SB; Forbes-Nelson AE
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Jun; 85(6):692-8. PubMed ID: 9638703
[TBL] [Abstract][Full Text] [Related]
4. Expression of Bcl-2 protein in hyperplastic polyps, adenomas, and carcinomas of the colon.
Flohil CC; Janssen PA; Bosman FT
J Pathol; 1996 Apr; 178(4):393-7. PubMed ID: 8691316
[TBL] [Abstract][Full Text] [Related]
5. Expression of proliferating cell nuclear antigen in gastrointestinal tract lesions and its relationship to bcl-2 expression.
Bell K; Bronner MP; Pasha T; Furth EE
Pathobiology; 1996; 64(2):91-8. PubMed ID: 8888274
[TBL] [Abstract][Full Text] [Related]
6. Topographical immunohistochemical expression of bcl-2 protein in human liver lesions.
Skopelitou A; Hadjiyannakis M; Alexopoulou V; Krikoni O; Kamina S; Agnantis N
Anticancer Res; 1996; 16(2):975-8. PubMed ID: 8687162
[TBL] [Abstract][Full Text] [Related]
7. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC
Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322
[TBL] [Abstract][Full Text] [Related]
8. Expression of p53, bcl-2, and Ki-67 proteins in the inflammatory regenerative and dysplastic epithelial lesions of flat colonic mucosa.
Radović S; Vukobrat-Bijedić Z; Selak I; Babić M
Bosn J Basic Med Sci; 2006 Feb; 6(1):39-45. PubMed ID: 16533178
[TBL] [Abstract][Full Text] [Related]
9. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis.
Sinicrope FA; Ruan SB; Cleary KR; Stephens LC; Lee JJ; Levin B
Cancer Res; 1995 Jan; 55(2):237-41. PubMed ID: 7812951
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical evidence of aberrant bcl-2 protein expression in gastric epithelial dysplasia.
Lauwers GY; Scott GV; Hendricks J
Cancer; 1994 Jun; 73(12):2900-4. PubMed ID: 8199986
[TBL] [Abstract][Full Text] [Related]
11. Expression of the BCL-2 protein in normal and dysplastic bronchial epithelium and in lung carcinomas.
Walker C; Robertson L; Myskow M; Dixon G
Br J Cancer; 1995 Jul; 72(1):164-9. PubMed ID: 7599047
[TBL] [Abstract][Full Text] [Related]
12. Detection of p53 and bcl-2 protein in carcinoma of the renal pelvis and ureter including dysplasia.
Furihata M; Sonobe H; Ohtsuki Y; Yamashita M; Morioka M; Yamamoto A; Terao N; Kuwahara M; Fujisaki N
J Pathol; 1996 Feb; 178(2):133-9. PubMed ID: 8683378
[TBL] [Abstract][Full Text] [Related]
13. Suppression of apoptosis does not foster neoplastic growth in Barrett's esophagus.
Soslow RA; Remotti H; Baergen RN; Altorki NK
Mod Pathol; 1999 Mar; 12(3):239-50. PubMed ID: 10102608
[TBL] [Abstract][Full Text] [Related]
14. Altered topographic expression of p21WAF1/CIP1/SDI1, bcl2 and p53 during gastric carcinogenesis.
Cho JH; Kim WH
Pathol Res Pract; 1998; 194(5):309-17. PubMed ID: 9651943
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical evaluation of bcl-2 protein expression in gastric adenocarcinomas.
Lauwers GY; Scott GV; Karpeh MS
Cancer; 1995 May; 75(9):2209-13. PubMed ID: 7712429
[TBL] [Abstract][Full Text] [Related]
16. Expression of c-myc in non-malignant and pre-malignant gastrointestinal disorders.
Ciclitira PJ; Macartney JC; Evan G
J Pathol; 1987 Apr; 151(4):293-6. PubMed ID: 3295155
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of bcl-2 expression in MALT lymphoma.
Ashton-Key M; Biddolph SC; Stein H; Gatter KC; Mason DY
Histopathology; 1995 Jan; 26(1):75-8. PubMed ID: 7713486
[TBL] [Abstract][Full Text] [Related]
18. Follicular lymphomas of the gastrointestinal tract. Pathologic features in 31 cases and bcl-2 oncogenic protein expression.
LeBrun DP; Kamel OW; Cleary ML; Dorfman RF; Warnke RA
Am J Pathol; 1992 Jun; 140(6):1327-35. PubMed ID: 1376556
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic problems and advances in inflammatory bowel disease.
Odze R
Mod Pathol; 2003 Apr; 16(4):347-58. PubMed ID: 12692200
[TBL] [Abstract][Full Text] [Related]
20. High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins.
Chatelain D; Fléjou JF
Virchows Arch; 2003 Jan; 442(1):18-24. PubMed ID: 12536310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
